SMTL ID : 8fll.1

Crystal structure of BTK kinase domain in complex with pirtobrutinib

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.50 Å
Oligo State
monomer
Ligands
1 x Y7W: pirtobrutinib(Non-covalent)
1 x SO4: SULFATE ION(Non-functional Binders)
2 x GOL: GLYCEROL(Non-functional Binders)
1 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Gomez, E.B. et al., Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor. Blood (2023)
Release Date
2023-03-01
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase BTK